window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

women’s health

  • Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Calla Lily selected for $50M Wellcome Leap antibiotic programme

    Calla Lily Clinical Care has been selected for Wellcome Leap’s [...]

    August 12, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Medicus Pharma gets UAE approval to start genomics-guided endometriosis study

    Medicus Pharma has received authorisation from the UAE Department of [...]

    July 31, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    Seegene data finds STI pathogens in 82% of HPV-positive test results

    Seegene analysis of about 60,000 test results found STI pathogens [...]

    July 28, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development

    IOTA founder recognised for global impact on ovarian tumour diagnosis

    The founder of the International Ovarian Tumor Analysis collaboration has [...]

    July 24, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    ReproNovo doses first participant in Phase 2 embryo implantation trial

    ReproNovo has dosed the first participant in a European Phase [...]

    July 6, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Gesynta reaches halfway point in Phase 2 endometriosis trial

    Gesynta Pharma has randomised half of the planned patients in [...]

    June 18, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Medicus files IND for genomics-enabled Phase 2 endometriosis trial

    Medicus Pharma has submitted an investigational new drug application in [...]

    June 11, 2026
  • Biotech & Pharma Business,Digital & Data,Therapeutic Areas

    Ultrahuman and Click Therapeutics partner on FDA-authorized digital migraine tool

    Ultrahuman and Click Therapeutics have entered a partnership to develop [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Opinion & Events,Therapeutic Areas

    Beyond the gap: Nordic experts call for investment and collaboration to advance women’s health

    Women’s health remains underfunded, underdiagnosed and undervalued — but a [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    Cook MyoSite and Veristat progress Phase 3 trial of cell therapy for women with chronic incontinence

    Cook MyoSite and Veristat have reached a key enrolment milestone [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Piramal Pharma reports 22.6% emissions reduction and zero OAI observations in sustainability report
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
  • FDA approves ViiV’s Tivicay PD for young children with HIV
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Centrix and University of Sussex launch £375,000 data science project for drug development
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top